$2.22
1.33% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US68236V1044
Symbol
ATNF
Sector
Industry

180 Life Sciences Corp Stock price

$2.22
-2.04 47.89% 1M
+0.60 37.04% 6M
-1.84 45.27% YTD
-3.73 62.66% 1Y
-1,692.58 99.87% 3Y
-4,018.18 99.94% 5Y
-3,683.78 99.94% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
-0.03 1.33%
ISIN
US68236V1044
Symbol
ATNF
Sector
Industry

Key metrics

Market capitalization $1.19m
Enterprise Value $1.48m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
P/B ratio (TTM) P/B ratio 0.61
Revenue (TTM) Revenue $0.00
EBIT (operating result TTM) EBIT $-6.37m
Free Cash Flow (TTM) Free Cash Flow $-2.69m
Cash position $190.00k
EPS (TTM) EPS $-4.81
Short interest 13.68%
Show more

Is 180 Life Sciences Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

180 Life Sciences Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast 180 Life Sciences Corp:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast 180 Life Sciences Corp:

Buy
100%

Financial data from 180 Life Sciences Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs 0.08 0.08
33% 33%
-
-0.08 -0.08
33% 33%
-
- Selling and Administrative Expenses 4.68 4.68
67% 67%
-
- Research and Development Expense 1.52 1.52
55% 55%
-
-6.29 -6.29
64% 64%
-
- Depreciation and Amortization 0.08 0.08
33% 33%
-
EBIT (Operating Income) EBIT -6.37 -6.37
64% 64%
-
Net Profit -3.12 -3.12
92% 92%
-

In millions USD.

Don't miss a Thing! We will send you all news about 180 Life Sciences Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

180 Life Sciences Corp Stock News

Neutral
Accesswire
26 days ago
PALO ALTO, CA / ACCESSWIRE / October 31, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the retention of Mr. Vaclav Vincalek as Senior Technology Consultant.
Neutral
Accesswire
28 days ago
PALO ALTO, CA / ACCESSWIRE / October 29, 2024 / 180 Life Sciences Corp. ("180" or the "Company") (NASDAQ:ATNF) today announced the appointment of Mr. Jay Goodman to its Board of Directors, effective immediately.
Positive
Invezz
about one month ago
180 Life Sciences Corp (NASDAQ: ATNF), a biotech firm, saw its shares skyrocket by 900% on Wednesday following the acquisition of a blockchain-enabled platform. This strategic move marks a significant shift in the company's focus as it pivots into the online gaming industry.
More 180 Life Sciences Corp News

Company Profile

180 Life Sciences Corp. develops pharmaceuticals for chronic pain and inflammatory diseases. It operates as a clinical-stage biotechnology company focused on the development of novel drugs that fulfil unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded in 2016 and is headquartered in Menlo Park, CA.

Head office United States
CEO Blair Jordan
Employees 4
Founded 2016
Website www.180lifesciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today